First in Human Study of TORL-3-600 in Participants With Advanced Cancer

NCT05948826 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Colorectal Cancer

Interventions

DRUG: TORL-3-600

Sponsor

TORL Biotherapeutics, LLC

Collaborators

[object Object]